You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: RE47769


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent RE47769 protect, and when does it expire?

Patent RE47769 protects EXONDYS 51 and is included in one NDA.

This patent has thirty patent family members in thirteen countries.

Summary for Patent: RE47769
Title:Antisense oligonucleotides for inducing exon skipping and methods of use thereof
Abstract: Antisense molecules capable of binding to a selected target site in the dystrophin gene to induce exon skipping are described.
Inventor(s): Wilton; Stephen Donald (Applecross, AU), Fletcher; Sue (Bayswater, AU), McClorey; Graham (Bayswater, AU)
Assignee: The University of Western Australia (Crawley, AU)
Application Number:15/349,535
Patent Claim Types:
see list of patent claims
 

Drugs Protected by US Patent RE47769

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sarepta Theraps Inc EXONDYS 51 eteplirsen SOLUTION;INTRAVENOUS 206488-001 Sep 19, 2016 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Sarepta Theraps Inc EXONDYS 51 eteplirsen SOLUTION;INTRAVENOUS 206488-002 Sep 19, 2016 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: RE47769

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Australia2004903474Jun 28, 2004
PCT Information
PCT FiledJune 28, 2005PCT Application Number:PCT/AU2005/000943
PCT Publication Date:January 05, 2006PCT Publication Number: WO2006/000057

International Family Members for US Patent RE47769

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria E498685 ⤷  Sign Up
Cyprus 1111447 ⤷  Sign Up
Cyprus 1117475 ⤷  Sign Up
Germany 602005026386 ⤷  Sign Up
Denmark 1766010 ⤷  Sign Up
Denmark 2206781 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.